hereditary ATTR amyloidosis

SFNP 2022 – Alnylam takes heart from its Onpattro follow-on
EP Vantage
Tue, 01/25/22 - 10:41 am
Alnylam
vutrisiran
Onpattro
hereditary ATTR amyloidosis
Intellia Aims Big with CRISPR Therapy to Cure ATTR
BioSpace
Tue, 10/20/20 - 10:44 am
Intellia Therapeutics
CRISPR
hereditary ATTR amyloidosis
NTLA-2001
Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis
CP Wire
Mon, 07/23/18 - 09:42 am
Alnylam
Patisiran
hereditary ATTR amyloidosis
Alnylam Presents Ph III results of Patisiran in Hereditary ATTR (hATTR) Amyloidosis
Mon, 07/23/18 - 09:40 am
Alnylam
hereditary ATTR amyloidosis
Patisiran
FDA Extends Action Date on Akcea's Inotersen, Alnylam Now in Lead
CP Wire
Fri, 05/4/18 - 09:58 am
Akcea
hereditary ATTR amyloidosis
FDA
inotersen
Alnylam
Patisiran
Alnylam Starts Rolling NDA Submission for RNAi Candidate
Yahoo/Zacks.com
Fri, 11/17/17 - 11:15 am
Alnylam
RNAi
hereditary ATTR amyloidosis
FDA
Patisiran